Skip to main content

Gossamer Bio, Inc.

GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001728117

No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Gossamer Bio, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of GOSS: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders100105+5
Shares174.9M171.4M−3.51M (−2.0%)
Value$172.6M$155.0M−$17.6M (−10.2%)

New holders (18)

Institutions that held Gossamer Bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to GOSS in Q4 2024
InstitutionSharesValue% of portfolio
Allostery Investments LP613,028$554.5K1.09%
Diadema Partners LP217,987$197.2K0.22%
Opti Capital Management, LP182,319$164.9K0.01%
Merriman Wealth Management, LLC142,269$128.7K0.01%
Jefferies Financial Group Inc.100,000$90.5K0.00%
Velan Capital Investment Management LP75,000$67.8K0.06%
Persistent Asset Partners Ltd65,894$65.5K0.06%
Fullcircle Wealth LLC47,954$62.8K0.03%
Graham Capital Management, L.P.34,947$31.6K0.00%
Callan Capital, LLC30,000$27.1K0.00%
XTX Topco Ltd21,339$19.3K0.00%
Jane Street Group, LLC12,774$11.6K0.00%
Rialto Wealth Management, LLC10,752$9.73K0.00%
Texas Yale Capital Corp.10,000$9.05K0.00%
SBI Securities Co., Ltd.9,117$8.25K0.00%
R Squared Ltd3,360$3.04K0.00%
Steward Partners Investment Advisory, LLC1,000$9050.00%
Farther Finance Advisors, LLC400$3620.00%

Sold out (13)

Institutions that held Gossamer Bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.